Jeremy Haigh is the CEO of Proteome Sciences, a leading company in applied proteomics and peptidomics. Prior to this he was the European Chief Operating Officer in Research & Development at Amgen. He was responsible for Amgen’s Research & Development sites across Europe, the Middle East and Africa (EMEA), and for Global Development staff located in the region.

Jeremy’s experience across the pharmaceutical sector in both clinical trials and organisational governance and development is vast.

His areas of expertise are clinical research – especially neurological diseases, leadership in the biosciences sector and organisational development.